UBS Maintains Sell on Aveanna Healthcare Hldgs, Raises Price Target to $5

Benzinga · 2d ago
UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Sell and raises the price target from $4.5 to $5.